Pure Global

DIRECTCHECK Whole Blood Control - Indonesia BPOM Medical Device Registration

DIRECTCHECK Whole Blood Control is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20208810532. The device is manufactured by ACCRIVA DIAGNOSTICS INC. from United States, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is DEMKA SAKTI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
DIRECTCHECK Whole Blood Control
Analysis ID: AKL 20208810532

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

United States

Authorized Representative

DEMKA SAKTI

AR Address

JLN. TANAH ABANG III/19 A-B, RT.002/RW.003

Registration Date

Nov 01, 2024

Expiry Date

Dec 31, 2028

Product Type

Hematological Reagents

Hematology quality control mixture.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name